Table 6 Subgroup analyses of methodological quality assessment (n/%).

From: Epidemiology Characteristics, Methodological Assessment and Reporting of Statistical Analysis of Network Meta-Analyses in the Field of Cancer

Items (Yes)

All NMAs (n = 102)

Journal impact factor*

Year of publication#

Funding source

Country of corresponding author

Type of NMAs

Low (<5.00) (n = 55) vs. High (≥5.00) (n = 32)

P-value

Older (n = 58) vs. Recent (n = 44)

P-value

Funding (n = 46) vs. Non-funding (n = 56)

P-value

China (n = 29) vs. Others (n = 73)

P-value

Bayesian NMAs (n = 61) vs. Adjusted indirect comparisons (n = 43)&

P-value

Was the research question (i.e., research purpose, inclusion and exclusion criteria) clarified?

62/60.78

31/56.36 vs. 20/62.50

0.568

33/56.90 vs. 29/65.91

0.358

26/56.52 vs. 36/64.29

0.426

20/68.97 vs. 42/57.53

0.288

38/62.30 vs. 25/58.14

0.671

Was there duplicate study selection and data extraction?

74/72.55

38/69.09 vs. 24/75.00

0.547

41/70.69 vs. 33/75.00

0.631

32/69.57 vs. 42/75.00

0.543

26/89.66 vs. 48/65.75

0.015

50/81.97 vs. 26/60.47

0.015

Was a comprehensive literature search performed?

58/56.86

25/45.45 vs. 25/78.13

0.002

31/53.45 vs. 27/61.36

0.426

26/56.52 vs. 32/57.14

0.950

16/55.17 vs. 42/57.53

0.829

43/70.49 vs. 17/39.53

0.002

Was the status of publication (i.e. grey literature) used as an inclusion criterion?

81/79.41

43/78.18 vs. 26/81.25

0.728

46/79.31 vs. 35/79.55

0.977

35/76.09 vs. 46/82.14

0.454

26/89.66 vs. 55/75.34

0.109

53/86.89 vs. 29/67.44

0.017

Was a list of included studies provided?

94/92.16

50/90.91 vs. 29/90.63

0.965

53/91.38 vs. 41/93.18

0.739

44/95.65 vs. 50/89.29

0.236

28/96.55 vs. 66/90.41

0.300

56/91.80 vs. 40/93.02

0.819

Were the characteristics of the included studies provided?

100/98.04

54/98.18 vs. 31/96.88

0.715

58/100.00 vs. 42/95.45

0.103

45/97.83 vs. 55/98.21

0.889

29/100.00 vs. 71/97.26

0.370

59/96.72 vs. 43/100.00

0.233

Was the scientific quality of the included studies assessed and documented?

70/68.63

34/61.82 vs. 25/78.13

0.098

32/55.17 vs. 38/86.36

0.001

29/63.04 vs. 41/73.21

0.273

25/86.21 vs. 45/61.64

0.016

48/78.69 vs. 24/55.81

0.013

Was the scientific quality of the included studies used appropriately in formulating conclusions?

31/30.39

11/20.00 vs. 8/25.00

0.584

12/20.69 vs. 19/43.18

0.015

9/19.57 vs. 22/39.29

0.032

20/68.97 vs. 11/15.07

0.000

21/34.43 vs. 10/23.26

0.222

Were the methods used to combine the findings of studies appropriate?

66/64.71

32/58.18 vs. 26/81.25

0.019

37/63.79 vs. 29/65.91

0.826

28/60.87 vs. 38/67.86

0.465

18/62.07 vs. 48/65.75

0.727

39/63.93 vs. 29/67.44

0.713

Was the likelihood of publication bias assessed?

16/15.69

3/5.45 vs. 8/25.00

0.017

10/17.24 vs. 6/13.64

0.622

5/10.87 vs. 11/19.64

0.228

6/20.69 vs. 10/13.70

0.383

8/13.11 vs. 9/20.93

0.291

Was the conflict of interest stated?

62/60.78

38/69.09 vs. 22/68.75

0.974

37/63.79 vs. 25/56.82

0.477

29/63.04 vs. 33/58.93

0.673

11/37.93 vs. 51/69.86

0.001

35/57.38 vs. 27/62.79

0.581

  1. *6 studies published in journals with no associated impact factor.
  2. #Based on the median division of number of included NMAs, December 31st 2013 is the cut-off point.
  3. &2 adjusted indirect comparisons also were conducted using Bayesian framework.